Filing Details

Accession Number:
0001209191-14-062466
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-08 16:11:48
Reporting Period:
2014-10-06
Filing Date:
2014-10-08
Accepted Time:
2014-10-08 16:11:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550395 David Altshuler C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-06 1,405 $63.14 1,405 No 4 M Direct
Common Stock Disposition 2014-10-06 1,405 $109.75 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-10-06 1,405 $0.00 1,405 $63.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,000 2022-05-23 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
  2. The option vests in 16 quarterly installments from 05/24/2012.